Evidence map›Paper›PMID 41714120›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2026

Reliability and Practicability of FAP-RADS Version 1.0 for Structured Reporting of FAPI Imaging in Pulmonary and Urothelial Carcinoma.

Emil Novruzov, Eduards Mamlins, Liam Widjaja, Sophie C Siegmund, Tadashi Watabe, Yuriko Mori, Christian Stief, Amanda Tufman, Ken Herrmann, Michael A Gorin and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Emil NovruzovDepartment of Nuclear Medicine, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine-University Duesseldorf, Düsseldorf, Germany; emil.novruzov@med.uni-duesseldorf.de.
Eduards MamlinsDepartment of Nuclear Medicine, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine-University Duesseldorf, Düsseldorf, Germany.
Liam WidjajaDepartment of Nuclear Medicine, LMU University Hospital, Munich, Germany.
Sophie C SiegmundDepartment of Nuclear Medicine, LMU University Hospital, Munich, Germany.
Tadashi WatabeDepartment of Radiology, Osaka University Graduate School of Medicine, Osaka, Japan.
Yuriko MoriDepartment of Nuclear Medicine, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine-University Duesseldorf, Düsseldorf, Germany.
Christian StiefDepartment of Urology, LMU University Hospital, Munich, Germany.
Amanda TufmanDepartment of Medicine V, LMU University Hospital, Munich, Germany.
Ken HerrmannDepartment of Nuclear Medicine, University of Duisburg-Essen, Essen, Germany.
Michael A GorinMilton and Carroll Petrie Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York.
Martin G PomperDepartment of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas.
Steven P RoweDepartment of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas.
Frederik L GieselDepartment of Nuclear Medicine, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine-University Duesseldorf, Düsseldorf, Germany.
Rudolf A WernerDepartment of Nuclear Medicine, LMU University Hospital, Munich, Germany.
Gabriel T SheikhDepartment of Nuclear Medicine, LMU University Hospital, Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, a collaborative effort among research centers in the United States and Europe resulted in the development of fibroblast activation protein reporting and data system (FAP-RADS) version 1.0, a reporting framework for fibroblast activation protein (FAP)-targeted imaging using the fundamental principles of the molecular imaging reporting and data systems framework. This retrospective study aimed to investigate the reliability and consistency of FAP-RADS version 1.0 framework for patients with lung cancer and urothelial cancer.

Indexed as

GelatinasesLung NeoplasmsMembrane ProteinsPositron Emission Tomography Computed TomographySerine EndopeptidasesUrologic NeoplasmsAgedEndopeptidasesFemaleFibroblast Activation Protein AlphaHumansMaleMiddle AgedObserver VariationReproducibility of ResultsRetrospective StudiesEndopeptidasesFibroblast Activation Protein AlphaGelatinasesMembrane ProteinsSerine EndopeptidasesFAP imagingFAP PETFAP-RADSRADS frameworkstandardized reporting

Identifiers

PMID41714120
PMCPMC13138100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.